Departamento
Farmacología
Publicaciones (44) Publicaciones en las que ha participado algún/a investigador/a
2013
-
A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach
Pediatric Drugs, Vol. 15, Núm. 3, pp. 247-257
-
A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior
Neuropsychopharmacology, Vol. 38, Núm. 9, pp. 1724-1736
-
Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain
European Journal of Pharmacology, Vol. 709, Núm. 1-3, pp. 13-19
-
An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure
Neuroscience Letters, Vol. 557, Núm. PB, pp. 101-106
-
Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: A pilot study of relationship to negative symptoms
Journal of Psychiatric Research, Vol. 47, Núm. 7, pp. 926-934
-
Antidepressant-like properties of three new α2-adrenoceptor antagonists
Neuropharmacology, Vol. 65, pp. 13-19
-
Antipsychotics and seizures: Higher risk with atypicals?
Seizure, Vol. 22, Núm. 2, pp. 141-143
-
Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.
Translational psychiatry, Vol. 3
-
Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment
Psychopharmacology, Vol. 226, Núm. 1, pp. 177-188
-
Calcium as main trigger of mitochondrial oxidant stress in Parkinson's disease
Movement Disorders
-
Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders (Springer New York), pp. 213-238
-
Chronic effects of corticosterone on GIRK1-3 subunits and 5-HT1A receptor expression in rat brain and their reversal by concurrent fluoxetine treatment
European Neuropsychopharmacology, Vol. 23, Núm. 3, pp. 229-239
-
Chronic pain leads to concomitant noradrenergic impairment and mood disorders
Biological Psychiatry, Vol. 73, Núm. 1, pp. 54-62
-
Cooperativity between calmodulin-binding sites in Kv7.2 channels
Journal of Cell Science, Vol. 126, Núm. 1, pp. 244-253
-
Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: Basal contents and effects of psychotropic medications
International Journal of Neuropsychopharmacology, Vol. 16, Núm. 3, pp. 683-689
-
Description of a bivalent cannabinoid ligand with hypophagic properties
Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179
-
Determination of total plasma hydroperoxides using a diphenyl-1- pyrenylphosphine fluorescent probe
Analytical Biochemistry, Vol. 434, Núm. 1, pp. 172-177
-
Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?
Current drug safety, Vol. 8, Núm. 1, pp. 63-68
-
Dopamine-dependent long-term depression at subthalamo-nigral synapses is lost in experimental parkinsonism
Journal of Neuroscience, Vol. 33, Núm. 36, pp. 14331-14341
-
Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects
European Neuropsychopharmacology, Vol. 23, Núm. 8, pp. 852-864